|

Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

RECRUITINGPhase 1Sponsored by Iran University of Medical Sciences
Actively Recruiting
PhasePhase 1
SponsorIran University of Medical Sciences
Started2024-08-01
Est. completion2026-01-01
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06543667

Summary

The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with complaints of burning or itching or feeling of a foreign body in the eye
* Moderate and severe dry eye severity
* Age between 18-70 years

Exclusion Criteria:

* Previous history of eye surgery
* Any disease that suppresses the immune system
* Pregnancy and breastfeeding
* Eyelid abnormalities
* Use of eye drops in the past year except artificial tears and lubricating ointments
* Use of systemic drugs that affect the tear film in last three months
* Use of contact lenses in the last three months

Conditions2

ArthritisDry Eye Syndromes

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.